Showing: 1 - 2 of 2 RESULTS
Rebounding

Expedia shifts spend from performance to loyalty as it adopts ‘long-term’ view of growth

Travel + Leisure Careers

Tomorrow, the economic performance of travel companies will depend on their ability to renew themselves by offering new experiences, while remaining adaptive to customers needs. Travel & Leasuire The reports covering Travel & Leisure industry offer trends analysis of various types. These include overall key growth opportunities in global Travel & Leisure industry.

The data demonstrates that vaccination with mRNA-1273 elicits a robust immune response across all dose levels as it produced neutralizing antibodies in all 45 patients. In the trial, each participant received a 25, 100 or 250 microgram dose, with 15 people in each dose group. The positive result has pushed the vaccine into the phase 3 trial, which is slated to start on Jul 27. The trial will enroll 30,000 participants across 87 locations, according to ClinicalTrials.gov. Participants in the experimental arm will receive a 100 microgram dose of the potential vaccine on …

Rebounding

Expedia shifts spend from performance to loyalty as it adopts ‘long-term’ view of growth

Travel + Leisure Careers

Tomorrow, the economic performance of travel companies will depend on their ability to renew themselves by offering new experiences, while remaining adaptive to customers needs. Travel & Leasuire The reports covering Travel & Leisure industry offer trends analysis of various types. These include overall key growth opportunities in global Travel & Leisure industry.

The data demonstrates that vaccination with mRNA-1273 elicits a robust immune response across all dose levels as it produced neutralizing antibodies in all 45 patients. In the trial, each participant received a 25, 100 or 250 microgram dose, with 15 people in each dose group. The positive result has pushed the vaccine into the phase 3 trial, which is slated to start on Jul 27. The trial will enroll 30,000 participants across 87 locations, according to ClinicalTrials.gov. Participants in the experimental arm will receive a 100 microgram dose of the potential vaccine on …